The company said its revenue for Q4 2023 was $10.89 billion, down 5% from $11.45 billion a year earlier, and that Core organic revenue growth declined 4%.

1. 01

   The company said its revenue for Q4 2023 was $10.89 billion, down 5% from $11.45 billion a year earlier, and that Core organic revenue growth declined 4%.

2. 02

   Thermo Fisher said its GAAP operating margin for Q4 2023 was 17.0% (16.3% a year earlier), its adjusted operating margin was 23.4% (22.4% a year earlier), and its adjusted EPS was $5.67 ($5.40 a year earlier).

3. 03

   The company said its annual revenue for 2023 was $42.86 billion, down 5% from $44.92 billion a year earlier. It said GAAP operating income was $6.86 billion ($8.39 billion a year earlier) and adjusted EPS was $21.55 ($23.24 a year earlier).

4. 04

   Thermo Fisher gave full-year 2024 guidance of revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00. It said it returned $3.5 billion to shareholders through stock buybacks and dividends in 2023.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.